Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
Published pharmacokinetic work describes a plasma half-life of only a few minutes after intravenous administration
AOD 9604 trial history The most promising AOD 9604 data came from a Phase 2b trial involving 300 obese participants over 12 weeks
Monthly: The Comparison Why not just get one larger dose each month
Always consult a healthcare provider for proper diagnosis and treatment
WARNINGS: Patients with early Leber's disease (hereditary optic nerve atrophy) who were treated with cyanocobalamin suffered severe and swift optic atrophy
US$ 22.11
US$ 25.87
US$ 21.58
US$ 20.43
US$ 25.89
